Clinical trial
A Phase I Study of Cyclotron-produced Tc-99m Pertechnetate (CPERT) in Patients With Thyroid Cancer
NCT01437254 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Cyclotron-produced Tc-99m Pertechnetate (CPERT) in Patients With Thyroid Cancer
- Lead sponsor
- AHS Cancer Control Alberta
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- January 31, 2015
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.